LFMD Q4 2023 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$182M

Q4 2023 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$45M+59.5% YoY

Gross Profit

$40M88.1% margin

Operating Income

-$2M-4.8% margin

Net Income

-$4M-8.3% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+16.2%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$3M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$58M

Total Liabilities

$53M

Stockholders' Equity

$4M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45M	$28M	+59.5%
Gross Profit	$40M	$24M	+64.2%
Operating Income	-$2M	-$10M	+79.1%
Net Income	-$4M	-$12M	+68.7%